United Kingdom · Question · Written question
UIN 1326
Innovative Medicines Fund: Gene Therapies
Original
Introduced
10 November 2023
Last action
16 November 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
16 November 2023
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the Innovative Medicines Fund in increasing access to gene therapies.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
10 November 2023
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the Innovative Medicines Fund in increasing access to gene therapies.
Source: Commons
16 November 2023
Answer
The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service in England on whether all new licensed medicines represent a clinically effective and cost-effective use of NHS resources. NICE has been abl...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-11-10/1326
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1669201
- uk · wq-1669201 · source updated 16 November 2023